It is notable that the EP300/CREBBP pathway mutational signatures uncovered in this study are also seen in diffuse large B-cell lymphoma, where they are associated with NOTCH activation via negative regulation of FBXW738. Here, EP300 is linked to diffuse large B-cell lymphoma.